31928
中文   |   English 手机浏览
当前位置： 首页   >  成果及论文
成果及论文

孙晓，山东省优青，泰山学者青年专家，齐鲁卫生与健康杰出青年，目前主持3项国家级项目（国自然面上项目、科技部国家外专等）、7项省部级项目；以第一/通讯作者在 Coordination Chemistry Reviews (2篇)、ACS Nano (5篇), Advanced Functional Materials (4篇), Bioactive Materials (3篇), Advanced Science (2篇), Biomaterials (2篇)等国际权威杂志发表系列SCI论文（IF>10论文35篇），总IF>500；已授权国家发明专利16项；获英国皇家化学会生物材料科学“新锐科学家”，获山东省教学成果奖一等奖、山东省科技进步二等奖、山东省材料科技奖一等奖、于金明科技创新奖、山东省医学科技奖三等奖等奖项；担任山东省多模态影像人工智能遗传学重点实验室副主任、山东省健康管理协会泛血管影像医学分会副主委等职务。获校“优秀教师”、“优秀党员”、教工党支部书记“双带头人”等荣誉称号；现为BMEMat等杂志青年编委及Science Advances、ACS Nano、AFM、Nano Letters、Bioactive Materials、Biomaterials等杂志审稿人。


发表论文情况

**2025年**

1. H. Liu, Y. Yang, N. Zhang, Y. Hou, Z. Zhang, X. Yu, Y. Huang, B. Yan, H. Zhou, M. Mu, Y. Gao, K. Guo, M. Yang*, X. Sun*. Overcoming Photothermal Resistance of Gastric Cancer by Bionic 2D lron-Based Nanoplatform with Precise CRlSPR/Cas9 Delivery. *ACS Nano*, 2025, 19, 18188−18202. (IF=16.0)

2. Y. Yuan, L. Tian, X. Liu, K. Guo, K. Ren, L. Yan, M. Mu, S. Liu, F. Teng, C. Liu,* P. Liang,* X. Sun*. Transferrin-Targeted Nanoarchitectonics with Efficient Metastasis Inhibition Enabling Tumor T1-T2 Dual-Mode Magnetic Resonance Contrast Enhancement. *Advanced Healthcare Materials*, 2025, 14, e00690. (IF=10)

3. M. Zhang, X. Zhang, C. Wang, M. Mu, K. Ren, N. Ni, L. X. Yip, K. Guo, X. Hu, F. Teng, D. T. Leong, Q. Fan*, X. Sun*. Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation Enteritis. *Advanced Science*, 2025, 12(33), e03602. (IF=14.1)

4. N. Ni, K. Xing, B. Wang, Y. Chen, J. Xie*, X. Sun*, J. Wang*, D. Leong*. Gold Nanoclusters as Dual Agents for Engineering Tumor Vascular Leakiness and Performing Photothermal Therapy. *Advanced Functional Materials*, 2025, 24258658. (IF=19)

5. M. Mu, M. Zhang, J. Liu, K. Ren, H. Liu, L. X. Yip, K. Guo, F. Teng, J. Dong, X. Xu*, D. T. Leong*, X. Sun*. Real-time magnetic resonance visualization of tumor acidosis as a precognition indicator of therapeutic efficacy. *Bioactive Materials*, 2025, 52, 63-72. (IF=20.3)

6. H. Zhou, X. Zhang, H. Liu, Y. Gao, M. Mu, Y. Tang*, T. Jiang, Z. Zhang, S. Liu, L. X. Yip, X. Sun*, Z. Liu*. Convertible ROS Nanogenerator/Eliminator for Enhanced Tumor Photothermal Therapy with Reduced Inflammatory Response. *Advanced Functional Materials*, 2025, 2422241. (IF=19)

7. S. Zhao, D. Jia, X. Qi, X. Bian, X. Song, X. Tang, X. Cui, J. Yuan, F. Wang, B. Tian, Y. Wang, Y. Wei, D. Yuan*, X. Sun*, Q. Fan*. Engineered PD-L1-targeted multifunctional proteins with self-prolonged circulation for enhanced tumor photothermal-immunotherapy. *Materials Today Bio*, 2025, 102596. (IF=10.2)

8. Y. Wang, Q. Zhang, B. Yan, L. Pang, Y. Ren, M. Inam, M. Zhang, N. Ni, X. Xu*, X. Sun*, S. Zhou*. Engineered Gadolinium-decorated magnetic resonance nanoprobes for enhanced liver fibrosis theranostics. *Advanced Healthcare Materials*, 2025, e03891. (IF=10)

9. J. Cui#, S. Zhang#, X. Xu#, K. Ren, M. Dong, Z. Nie, Y. Xu, X. Dai, P. Xu, S. Sun, X. Zhao*, X. Sun*. Recent advances of nanomaterials in imaging liver fibrosis. *BMEMat*, 2025, 3, e12123. (IF=15.5, Back Cover)

10. X. Sun, Y. Gong, H. Ge, G. Ma, T. Yang, M. Mu, L. Zhang, C. Wang, B. Shen, X. Dai, Z. Wu, X. Zhang*, Q. Fan*, H. Sun*.Engineered Magnetic Resonance Nanoprobesfor Visualizing Tumor Programmed Cell Death Ligand 1 Level and Enhancing Synergistic Radio Immunotherapy*ACS Nano*, 2025, 19(41), 36158–36170. (IF=16.1)

11. Y. Gao, M. Mu, Y. Wei, B. Yan, H. Liu, K. Guo*, M. Zhang, X. Dai, X. Sun*, D. T. Leong*. Novel Ultrathin Ferrous Sulfide Nanosheets: Towards Replacing Black Phosphorus in Anticancer Nanotheranostics. *Bioactive Materials*, 2025, 43, 564-578. (IF=20.3)

12. H. Zhou, H. Liu, M. Mu, S. Liu, Y. Gao, K. Guo, M. Zhang, N. Ni, F. Teng, Y. Tang, H. Sun*, D. Chen*, X. Sun*. Photothermal-Triggered Radical Storm for Achieving Multi-Layered PD-Ll Inhibition in Cancer Theranostics. *Chemical Engineering Journal*, 2025, 513, 162636. (IF=13.2)

13. X. Zhang, H. Liu, C. Wang, Y. Gao, S. Zhao, M. Mu, K. Ren, Y. Gong, Q. Fan*, X. Sun*. Dimeric PD-L1 Specific Affibody Grafted Fe-Based Nanosheets for Tumor-Targeting Dual-Mode Magnet Resonance Imaging and Enhancement of Photothermal-Immunotherapy. *Chemical Engineering Journal*, 2025, 159400. (IF=13.2)

14. K. Guo, H. Liu, M. Zhang, N. Ni, M. Mu, K. Ren, J. Chen, Q. Fan, X. Xu, X. Sun*, X. Wang*. Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy. *Chemical Engineering Journal*, 2025, 504, 158754. (IF=13.2)

15. Liya Tian Xiao Sun, Shunzhen Zheng. A transferrin-targeted nanoplatform for MRI-guided visualization and potent suppression of tumors and pulmonary metastatic lesions. Nanoscale Horizons, 2025, 10, 2422-2433. (IF=6.6)

16. Muhammad Inam,† Ke Ren,† Bowen Shen, Fangyu Zhou, Liya Tian, Jie Liu*, Xiao Sun*. Engineered PD-L1 nanoregulators for enhanced tumor immunotherapy Biomaterials Science, 2025,13, 4663-4680. (IF=5.7)

17. Y. Wang, S. Zhao, N. Ni, H. Chen, W. Zhao, K. Xing, X. Sun*, X. Jing*. Nanoparticles induced glomerular endothelial leakiness promoting albuminuria level. *NanoImpact*, 2025, 37, 100548. (IF=5.5)

18. Q. Xiao, Q. Jia, M. Inam, Q. Chen, X. Sun*. Medical Gas Research, 2025, 15, 214-215. (IF=3.0)

19. Zhao et al, Xiao Sun*. *ACS Nano*, 2025, Major Revision.

20. K. R. Xing et al, Xiao Sun*, David Leong*. *Cell*, Major Revision.


**2024年**

17. J. Cui#, G. Wang#, L. X. Yip#, M. Dong, M. Mu, L. Tian, Y. Gao, Q. Fan, Q. Zhu, X. Zhao*, X. Xu*, D. T. Leong*, X. Sun*. Enhanced ferritin-manganese interaction by nanoplatinum growth enabling liver fibrosis three-dimensional magnetic resonance visualization and synergistic therapy with real-time monitoring. *Advanced Functional Materials*, 2024, 2410748. (IF=19)

18. H. Liu, X. Dai, N. Li, L. Zhang, Z. Wang, K. Ren, Y. Li,* J. Wan*, X. Sun*. Injectable Magnetic Hydrogel Incorporated with Anti-inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis. *Advanced Science*, 2024, 2409778. (IF=14.1)

19. H. Liu, M. Mu, Y. Hou, Y. Gong, C. Wang, G. Ma, K. Guo, L. Ma*, X. Sun*. A Novel CRISPR/Cas9-Encapsulated Biomimetic Manganese Sulfide Nanourchins for Targeted Magnetic Resonance Contrast Enhancement and Self-Enhanced Chemodynamics-Gene-Immune Synergistic Tumor Therapy. *Advanced Functional Materials*, 2024, 202401370. (IF=19)

20. G. Ma#, X. Zhang#, K. Zhao#, S. Zhang, K. Ren, M. Mu, C. Wang, X. Wang, H. Liu*, J. Dong*, X. Sun*. Polydopamine nanostructure-enhanced water interaction with pH-responsive manganese sulfide nanoclusters for tumor magnetic resonance contrast enhancement and synergistic ferroptosis-photothermal therapy. *ACS Nano*, 2024, 18(4), 3369-3381. (IF=16)

21. M. Mu, M. Zhang, Y. Gong, K. Guo, H. Liu, Z. Zhang, T. Jiang, H. Zhou, Q. Fan, D. Jia*, Y. Li*, X. Sun*. A multifunctional nanoplatform capable of dual action on tumor PD-L1 for enhanced cancer theranostics. *Chemical Engineering Journal*, 2024, 502, 158139. (IF=13.2)

22. Y. Gong#, K. Guo#, S. Cai, K. Ren, L. Tian, Y. Wang, M. Mu, Q. Meng*, J. Liu*, X. Sun*. Customized Sized Manganese Sulfide Nanospheres as Efficient T1 MRI Contrast Agents for Enhanced Tumor Theranostics. *Biomaterials Research*, 2024, 28, 0116. (IF=11.6)

23. C. Wang, W. Tian, X. Dai, J. Yuan, N. Ni, Q. Fan, H. Liu, H. Sun*, J. Wan*, X. Sun*. Calcium ascorbate loaded ultrathin ferrous sulfide nanosheets thermo-sensitive hydrogels for near-infrared light activation of synergistic endometriosis therapy. *Chemical Engineering Journal*, 2024, 496, 153740. (IF=15.1)

24. S. Liu, L. Tian, M. Mu, Z. Liu, M. Dong, Y. Gong, X. Wang, H. Zhang*, Q. Meng*, X. Sun*. Platinum Nanoparticles-Enhanced Ferritin-Mn2+ Interaction for Magnetic Resonance Contrast Enhancement and Efficient Tumor Photothermal Therapy. *Advanced Healthcare Materials*, 2024, 2303939. (IF=10)


**2023年**

25. X. Xu#, S. Xu#, J. Wan#, D. Wang, X. Pang, Y. Gao, N. Ni, D. Chen*, X. Sun*. Disturbing Cytoskeleton by Engineered Nanomaterials for Enhanced Cancer Therapeutics. *Bioactive Materials*, 2023, 29, 50–71. (IF=18.9)

26. W. Tian, C. Wang, R. Chu, H. Ge, X. Sun*, M. Li*. Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic therapy. *Biomaterials Research*, 2023, 27, 100. (IF=15.863)

27. Y. Gao, S. Liu, H. Liu, H. Ge, M. Zhang, C. Zhao, Y. Gong, X. Zhang, C. Wang*, X. Sun*, Z. Wu*. Application of oxygen vacancy defects in enhanced anti-cancer nanomedicine. *Science China Chemistry*, 2023, 66, 2492-2512. (IF=9.6)

28. X. Zhang, X. Xu, H. Liu, N. Ni, S. Liu, Y. Gong, G. Ma, L. Song, Q. Fan*, Q. Meng*, X. Sun*. CCR2-overexpressing Biomimetic Carrier-free Nanoplatform for Enhanced Cascade Ferroptosis Tumor Therapy. *Acta Biomaterialia*, 2023, 166, 604-614. (IF=10.633)

29. X. Xu, A. Liu, S. Liu, Y. Ma, X. Zhang, M. Zhang, J. Zhao, S. Sun, X. Sun*. Application of Molecular Dynamics Simulation in Self-assembled Cancer Nanomedicine. *Biomaterials Research*, 2023, 27, 39. (IF=15.863)

30. S. Xu, X. Pang, X. Zhang, Q. Lv, M. Zhang, J. Wang, N. Ni, X. Sun*. Nanomaterials disrupting cell-cell junctions towards various diseases. *Nano Research*, 2023, 16, 7053–7074. (IF=10.263)

31. X. Zhang, H. Ge, Y. Ma, L. Song, Y. Ma, G. Tian, L. Wang, Q. Meng*, X. Sun*. Engineered Anti-cancer Nanomedicine for Synergistic Ferroptosis-Immunotherapy. *Chemical Engineering Journal*, 2023, 455, 140688. (IF=16.744)

32. M. Liu, J. Yuan, G. Wang, N. Ni, Q. Lv, S. Liu, Y. Gong, X. Zhao, X. Wang*, X. Sun*. Shape Programmable T1-T2 Dual-Mode MRI Nanoprobes for Cancer Theranostics. *Nanoscale*, 2023, 15, 4694-4724. (IF=8.31)

33. G. Ma, K. Wang, X. Pang, S. Xu, Y. Liang, J. Yang, X. Zhang, X. Sun*, J. Dong*. Self-assembled nanomaterials for ferroptosis-based cancer theranostics. *Biomaterials Science*, 2023, 11, 1962-1980. (IF=7.59)

34. C. Wang, Y. Wang, W. Tian, S. Li, J. Wan, Y. Wang, L. Tian, X. Wang, C. Li, J. Wan*, X. Sun*. Application of nanomaterials with sulfur vacancy for enhanced cancer theranostics. *Nano TransMed*, 2023, 2, 100007.

35. W. Wang, X. Pang, M. Dong, R. Li, Z. Liu, Y. Liang, H. Liu, N. Ni, D. Chen* X. Sun*. Recent advances of nanomaterials promoting tumor metastasis. *Environment & Health*, 2023, 1, 367-382. (Supplementary Cover)

36. H. Wang, X. Zhao, H. Zhang, X. Zou, D. Jia, W. Liu, B. Tian, D. Yuan, Y. Li, Y. Zhu, F. Zhang, Y. Dai, Y. Fan, Y. Wei, X. Sun, Q. Fan, J. Dong. EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy. *Materials Today Advances*, 2023, 18, 100375. (IF=9.918)

37. T. Tang, Y. Gong*, Y. Gao, X. Pang, S. Liu, Y. Xia, D. Liu, L. Zhu, Q. Fan*, X. Sun*. A pH-Responsive Liposomal Nanoplatform for Co-delivery of a Pt(IV) Prodrug and Cinnamaldehyde for Effective Tumor Therapy. *Frontiers in Bioengineering and Biotechnology*, 2023, 1191534. (IF=6.064)


**2022年**

38. Y. Xu, Z. Nie, N. Ni, X. Zhang, J. Yuan, Y. Gao, Y. Gong, S. Liu, M. Wu*, X. Sun*. Shield-Activated Two-Way Imaging Nanomaterials for Enhanced Cancer Theranostics. *Biomaterials Science*, 2022, 10, 6893-6910. (IF=7.590)

39. N. Ni, X. Zhang, Y. Ma, J. Yuan, D. Wang, G. Ma, J. Dong*, X. Sun*. Biodegradable Two-Dimensional Nanomaterials for Cancer Theranostics. *Coordination Chemistry Reviews*, 2022, 458, 214415. (IF=24.833)

40. J. Liu, M. Huang, X. Zhang, Z. Hua, Z. Feng, Y. Dong, T. Sun*, X. Sun*, C. Chen*. Polyoxometalate Nanomaterials for Enhanced Reactive Oxygen Species Theranostics. *Coordination Chemistry Reviews*, 2022, 472, 214785. (IF=24.833)

41. N. Ni, W. Wang, Y. Sun, X. Sun*, D. T. Leong*. Inducible endothelial leakiness in nanotherapeutic applications. *Biomaterials*, 2022, 287, 121640. (IF=15.304)

42. H. Zhang, M. Zhang, X. Zhang, Y. Gao, Y. Ma, H. Chen, J. Wan, C. Li, F. Wang*, X. Sun*. Enhanced postoperative cancer therapy by iron-based hydrogels. *Biomaterials Research*, 2022, 26, 19. (IF=15.863)

43. Y. Cao, K. Wang, P. Zhu, X. Zou, G. Ma, W. Zhang, D. Wang, J. Wan, Y. Ma, X. Sun*, J. Dong*. A near-infrared triggered upconversion/MoS2 nanoplatform for tumour-targeted chemo-photodynamic combination therapy. *Colloids and Surfaces B: Biointerfaces*, 2022, 213, 112393. (IF=5.999)

44. X. Zou, G. Ma, P. Zhu, Y. Cao, X. Sun*, H. Wang*, J. Dong*. A Polydopamine-Coated Platinum Nanoplatform for Tumor Targeted Photothermal Ablation and Migration Inhibition. *Frontiers in Oncology*, 2022, 12, 860718. (IF=5.738)

45. D. Wang, Y. Wang, Q. Lv, X. Zhang, G. Ma, Y. Gao, C. Wang, S. Liu, C. Li*, X. Sun*, J. Wan*. A polyoxometalate encapsulated metal-organic framework nanoplatform for synergistic photothermal-chemotherapy and anti-inflammatory of ovarian cancer. *Molecules*, 2022, 27(23), 8350. (IF=4.927)


**2021年及更早**

46. X. Zhang, Y. Ma, J. Wan, J. Yuan, D. Wang, W. Wang, X. Sun*, Q. Meng*. Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics. *Frontiers in Chemistry*, 2021, 9, 768248. (IF=5.545)

47. N. Ni, Y. Su, Y. Wei, Y. Ma, L. Zhao*, X. Sun*. Tuning nanosiliceous framework for enhanced cancer theranostic applications. *Advanced Therapeutics*, 2021, 16, 2000218. (IF=5.003)

48. X. Sun*, N. Ni, Y. Ma, Y. Wang, D. T. Leong*. Retooling Cancer Nanotherapeutics' Entry into Tumors to Alleviate Tumoral Hypoxia. *Small*, 2020, 16, 2003000. (IF=15.153)

49. X. Sun#, G. Zhang#, R. Du#, R. Xu, D. Zhu, J. Qian, G. Bai, C. Yang, Z. Zhang, X. Zhang, D. Zou*, Z. Wu*. A Biodegradable MnSiO3@Fe3O4 Nanoplatform for Dual-Mode MR Imaging Guided Combinatorial Cancer Therapy. *Biomaterials*, 2019, 194, 151-160. (IF=15.304)

50. X. Sun#, M. Zhang#, R. Du#, X. Zheng, C. Tang, Y. Wu, J. He, W. Huang, Y. Wang, Z. Zhang, X. Han, J. Qian, K. Zhong, X. Tian, L. Wu, G. Zhang, Z. Wu*, D. Zou*. A polyethyleneimine-driven self-assembled nanoplatform for fluorescence and MR dual-mode imaging guided cancer chemotherapy. *Chemical Engineering Journal*, 2018, 350, 69-78. (IF=16.744)

51. X. Sun#, R. Du#, L. Zhang#, G. Zhang, X. Zheng, J. Qian, X. Tian, J. Zhou, J. He, Y. Wang, Y. Wu, K. Zhong, D. Cai*, D. Zou*, Z. Wu*. A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy. *ACS Nano*, 2017, 11, 7049-7059. (IF=18.027)







  1. H. Liu, Y. Yang, N. Zhang,Y. Hou, Z. Zhang, X. Yu, Y. Huang, B. Yan, H. Zhou, M. Mu, Y. Gao, K. Guo, M. Yang*, X. Sun*. Overcoming Photothermal Resistance of Gastric Cancer by Bionic 2D lron-Based Nanoplatform with Precise CRlSPR/Cas9 Delivery. ACS Nano, 2025, 19, 18188−18202.  (IF=16.0)
  2. Yinuo Yuan, Liya Tian, Xinyu Liu, Kai Guo, Ke Ren, Lei Yan, Mengyao Mu, Shangui Liu,Feifei Teng, Cun Liu,* Ping Liang,* and Xiao Sun*. Transferrin-Targeted Nanoarchitectonics with Efficient Metastasis Inhibition Enabling Tumor T1-T2 Dual-ModeMagnetic Resonance Contrast Enhancement. Advanced Healthcare Materials. 2025, 14, e00690 (IF=10)
  3. Mengmeng Zhang, Xinyu Zhang, Chenyu Wang, Mengyao Mu, Ke Ren, Nengyi Ni, Li Xian Yip, Kai Guo, Xiaoyu Hu, Feifei Teng, David Tai Leong, Qing Fan*, Xiao Sun*. Convertible ROS Nanocatalyst/Eliminator for Enhancing Tumor Radio-Immunotherapy and Relieving Radiation Enteritis. Advanced Science, 2025, 12(33):e03602.  (IF=14.1)
  4. Nengyi Ni, Kuoran Xing, Baoteng Wang，Yinglu Chen,  Jianping Xie*,  Xiao Sun*, Jinping Wang*, David Leong*. Gold Nanoclusters as Dual Agents for Engineering Tumor Vascular Leakiness and Performing Photothermal Therapy. Advanced Functional Materials, 202528658 (IF=19)
  5. Mengyao Mu, Mengmeng Zhang, Jie Liu, Ke Ren, Hui Liu, Lixian Yip, Kai Guo, Feifei Teng, Jian Dong, Xueli Xu*, David Tai Leong*, Xiao Sun*. Real-time magnetic resonance visualization of tumor acidosis as a precognition indicator of therapeutic efficacy. Bioactive Materials, 2025, 52, 63-72. (IF=20.3) 
  6. H. Zhou, X. Zhang, H. Liu, Y. Gao, M. Mu, Y. Tang*, T. Jiang, Z. Zhang, S. Liu, L. X. Yip, X. Sun*, Z. Liu*. Convertible ROS Nanogenerator/Eliminator for Enhanced Tumor Photothermal Therapy with Reduced Inflammatory Response. Advanced Functional Materials, 2025, 2422241. (IF=19)
  7. Shiqi Zhao, Dianlong ]ia, Xiaoyun Qi, Xin Bian, Xiaoyu Song, Xiaohui Tang, Xiaoxuan Cui, jupeng Yuan, Fei Wang, Baoqing Tian, Yiyao Wang, Yuchun Wei, Dandan Yuan*, Xiao Sun*, Qing Fan*.  Engineered PD-L1-targeted multifunctiona proteins with self-prolonged circulation forenhanced tumor photothermal-immunotherapy. Materials Today Bio, 2025, 102596. (IF=10.2)
  8. Y. Wang, Q. Zhang, B. Yan, L. Pang, Y. Ren, M. Inam, M. Zhang, N. Ni, X. Xu*, X. Sun*, S. Zhou*. Engineered Gadolinium-decorated magnetic resonance nanoprobes for enhanced liver fibrosis theranostics. Advanced Healthcare Materials. 2025, 0, e03891 (IF=10)
  9. J. Cui#, S. Zhang#, X. Xu#, K. Ren, M. Dong, Z. Nie, Y. Xu, X. Dai, P. Xu, S. Sun, X. Zhao*, X. Sun*.  Recent advances of nanomaterials in imaging liver fibrosis. BMEMat. 2025, 3: e12123. (IF =15.5, Back Cover)   
  10. X. Sun, Y. Gong, H. Ge, G.  Ma, T. Yang, M. Mu, L. Zhang, C. Wang, B. Shen, X. Dai, Z. Wu, X. Zhang*, Q. Fan*, H. Sun*. A novel magnetic resonance nanoprobe for visualizingtumor PD-L1 level and enhancing synergistic radio-immunotherapy. ACS Nano,  2025, 19, 41, 36158–36170 (IF=16.1)
  11. Zhao et al, Xiao Sun*. ACS Nano, 2025, Major Revision. 
  12. K.R. Xing et al, Xiao Sun*, David Leong.* Cell, Under Review.
  13. J. Cui#, G. Wang#, L.X. Yip#, M. Dong, M. Mu, L. Tian, Y. Gao, Q. Fan, Q. Zhu, X. Zhao*, X. Xu*, D. T. Leong*, X. Sun*. Enhanced ferritin-manganese interaction by nanoplatinum growth enabling liver fibrosis three-dimensional magnetic resonance visualization and synergistic therapy with real-time monitoring. 2024, Advanced Functional Materials. 2024, 2410748. (IF=19) 
  14. H. Liu, X. Dai, N. Li, L. Zhang, Z. Wang, K. Ren, Y. Li,* J. Wan*, X. Sun,* . Injectable Magnetic Hydrogel Incorporated with Anti-inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis. Advanced Science, 2024, 2409778.  (IF=14.1)
  15. H. Liu, M. Mu, Y. Hou, Y. Gong, C. Wang, G. Ma, K. Guo, L. Ma*, X. Sun*. A Novel CRISPR/Cas9-Encapsulated Biomimetic Manganese Sulfide Nanourchins for Targeted Magnetic Resonance Contrast Enhancement and Self-Enhanced Chemodynamics-Gene-Immune Synergistic Tumor Therapy. Advanced Functional Materials, 2024, 202401370. (IF=19)
  16. G. Ma#, X. Zhang#, K. Zhao#, S. Zhang, K. Ren, M. Mu, C. Wang, X. Wang, H. Liu*, J. Dong*, X. Sun*. Polydopamine nanostructure-enhanced water interaction with pH-responsive manganese sulfide nanoclusters for tumor magnetic resonance contrast enhancement and synergistic ferroptosis-photothermal therapy. ACS Nano, 2024, 18, 4, 3369-3381. (IF=16）
  17. Y. Gao, M. Mu, Y. Wei, B. Yan, H. Liu, K. Guo*, M. Zhang, X. Dai, X. Sun,*, D. T. Leong*. Novel Ultrathin Ferrous Sulfide Nanosheets: Towards Replacing Black Phosphorus in Anticancer Nanotheranostics. Bioactive Materials. 2025, 43, 564-578. (IF=20.3) 
  18. H. Zhou, H. Liu, M. Mu, S. Liu, Y. Gao, K. Guo, M. Zhang, N. Ni, F. Teng, Y. Tang, H. Sun,* D. Chen,* X. Sun*. Photothermal-Triggered Radical Storm for Achieving Multi-Layered PD-Ll Inhibition in Cancer Theranostics. Chemical Engineering Journal, 2025, 513, 162636. (IF=13.2)
  19. X. Zhang, H. Liu, C. Wang, Y. Gao, S. Zhao, M. Mu, K. Ren, Y. Gong, Q. Fan*, X. Sun*. Dimeric PD-L1 Specific Affibody Grafted Fe-Based Nanosheets for Tumor-Targeting Dual-Mode Magnet Resonance Imaging and Enhancement of Photothermal-Immunotherapy. Chemical Engineering Journal, 2025, 159400. (IF=13.2)
  20. K. Guo, H. Liu, M. Zhang, N.Ni, M. Mu, K. Ren, J. Chen, Q. Fan, X. Xu, X. Sun*, X. Wang*. Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy. Chemical Engineering Journal, 2025, 504, 158754. (IF=13.2) 
  21. Y. Wang, S. Zhao, N. Ni, H. Chen, W. Zhao, K. Xing, X. Sun*, X. Jing*. Nanoparticles induced glomerular endothelial leakiness promoting albuminuria level. NanoImpact, 2025, 37, 100548.(IF=5.5)
  22. M. Mu , M. Zhang, Y. Gong, K. Guo, H. Liu, Z. Zhang, T. Jiang, H. Zhou, Q. Fan, D. Jia*, Y. Li*, X. Sun*, A multifunctional nanoplatform capable of dual action on tumor PD-L1 for  enhanced cancer theranostics. Chemical Engineering Journal, 2024, 502, 158139.  (IF=13.2) 
  23. Y. Gong#, K. Guo#, S. Cai, K. Ren, L. Tian, Y. Wang, M. Mu, Q. Meng*, J. Liu*, X. Sun*. Customized Sized Manganese Sulfide Nanospheres as Efficient T1 MRI Contrast Agents for Enhanced Tumor Theranostics. Biomaterials Research,  2024, 28, 0116. (IF=11.6)  
  24. Chenyu Wang, Wei Tian, Xiaohui Dai, Jupeng Yuan, Nengyi Ni, Qing Fan, Hui Liu, Hongzan Sun*, Jipeng Wan*, Xiao Sun*. Calcium ascorbate loaded ultrathin ferrous sulfide nanosheets thermo-sensitive hydrogels for near-infrared light activation of synergistic endometriosis therapy. Chemical Engineering Journal, 2024, 496, 153740.  (IF=15.1)
  25. S. Liu, L. Tian, M. Mu, Z. Liu, M. Dong, Y. Gong, X. Wang, H. Zhang*, Q. Meng*, X. Sun*. Platinum Nanoparticles-Enhanced Ferritin-Mn2+ Interaction for Magnetic Resonance Contrast Enhancement and Efficient Tumor Photothermal Therapy, Advanced Healthcare Materials, 2024, 2303939. (IF=10)

  26. Q. Xiao, Q. Jia, M. Inam, Q. Chen, X. Sun*. Medical Gas Research. 2025, 15, 214-215. (IF=3.0)

  27. X. Xu#, S. Xu#, J. Wan#, D. Wang, X. Pang, Y. Gao, N. Ni, D. Chen*, X. Sun*. Disturbing Cytoskeleton by Engineered Nanomaterials for Enhanced Cancer Therapeutics. Bioactive Materials, 2023, 29, 50–71. (IF=18.9)
  28. W. Tian, C. Wang, R. Chu, H. Ge, X. Sun*, M. Li*. Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic  therapy. Biomaterials Research, 2023, 27, 100. (IF=15.863)
  29. Y. Gao, S. Liu, H. Liu, H. Ge, M. Zhang, C. Zhao, Y. Gong, X. Zhang, C. Wang*, X. Sun*, Z. Wu*. Application of oxygen vacancy defects in enhanced anti-cancer nanomedicine. Science China Chemistry, 2023, 66, 2492-2512. (IF=9.6)
  30. X. Zhang, X. Xu, H. Liu, N. Ni, S. Liu, Y. Gong, G. Ma, L. Song, Q. Fan*, Q. Meng*, X. Sun*. CCR2-overexpressing Biomimetic Carrier-free Nanoplatform for Enhanced Cascade Ferroptosis Tumor Therapy. Acta Biomaterialia, 2023, 166, 604-614. (IF=10.633)
  31. X. Xu, A. Liu, S. Liu, Y. Ma, X. Zhang, M. Zhang, J. Zhao, S. Sun, X. Sun*. Application of Molecular Dynamics Simulation in Self-assembled Cancer Nanomedicine. Biomaterials Research, 2023, 27, 39. (IF=15.863)

  32. S. Xu, X. Pang, X. Zhang, Q. Lv, M. Zhang, J. Wang, N. Ni, X. Sun*. Nanomaterials disrupting cell-cell junctions towards various diseases. Nano Research, 2023, 16, 7053–7074. (IF=10.263) 

  33. X. Zhang, H. Ge, Y. Ma, L. Song, Y. Ma, G. Tian, L. Wang, Q. Meng*, X. Sun*. Engineered Anti-cancer Nanomedicine for Synergistic Ferroptosis-Immunotherapy. Chemical Engineering Journal, 2023, 455, 140688. (IF=16.744)

  34. M. Liu, J. Yuan, G. Wang, N. Ni, Q. Lv, S. Liu, Y. Gong, X. Zhao, X. Wang*, X. Sun*. Shape Programmable T1-T2 Dual-Mode MRI Nanoprobes for Cancer Theranostics. Nanoscale, 2023,15, 4694-4724. (IF=8.31)

  35. G. Ma, K. Wang, X. Pang, S. Xu, Y. Liang, J. Yang, X. Zhang, X. Sun*, J. Dong*. Self-assembled nanomaterials for ferroptosis-based cancer theranostics. Biomaterials Science, 2023,11, 1962-1980. (IF=7.59)

  36. C. Wang, Y. Wang, W. Tian, S. Li, J. Wan, Y. Wang, L. Tian, X. Wang, C. Li, J. Wan*, X. Sun*. Application of nanomaterials with sulfur vacancy for enhanced cancer theranostics. Nano TransMed. 2023, 2, 100007.

  37. W. Wang, X. Pang, M. Dong, R. Li, Z. Liu, Y. Liang, H. Liu, N. Ni, D. Chen* X. Sun*. Recent advances of nanomaterials promoting tumor metastasis. Environment & Health, 2023, 1, 367-382. (Supplementary Cover) 

  38. Y. Xu, Z. Nie, N. Ni, X. Zhang, J. Yuan, Y. Gao, Y. Gong, S. Liu, M. Wu*, X. Sun*. Shield-Activated Two-Way Imaging Nanomaterials for Enhanced Cancer Theranostics. Biomaterials Science, 2022, 10, 6893-6910. (IF=7.590)

  39. N. Ni, X. Zhang, Y. Ma, J. Yuan, D. Wang, G. Ma, J. Dong*, X. Sun*. Biodegradable Two-Dimensional Nanomaterials for Cancer Theranostics. Coordination Chemistry Reviews, 2022, 458, 214415. (IF=24.833）
  40. J. Liu, M. Huang, X. Zhang, Z. Hua, Z. Feng, Y. Dong, T. Sun*, X. Sun*, C. Chen*. Polyoxometalate Nanomaterials for Enhanced Reactive Oxygen Species Theranostics. Coordination Chemistry Reviews, 2022, 472，214785. (IF=24.833）
  41.  N. Ni, W. Wang, Y. Sun, X. Sun*, D. T. Leong*. Inducible endothelial leakiness in nanotherapeutic applications. Biomaterials, 2022, 287, 121640. (IF=15.304）
  42.  H. Zhang, M. Zhang, X. Zhang, Y. Gao, Y. Ma, H. Chen, J. Wan, C. Li, F. Wang*, X. Sun*. Enhanced postoperative cancer therapy by iron-based hydrogels. Biomaterials Research, 2022, 26, 19. (IF=15.863）
  43.  X. Sun#, R. Du#, L. Zhang#, G. Zhang, X. Zheng, J. Qian, X. Tian, J. Zhou, J. He, Y. Wang, Y. Wu, K. Zhong, D. Cai*, D. Zou*, Z. Wu*. A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy. ACS Nano, 2017, 11, 7049-7059.（IF=18.027）
  44.  X. Sun#, G. Zhang#, R. Du#, R. Xu, D. Zhu, J. Qian, G. Bai, C. Yang, Z. Zhang, X. Zhang, D. Zou*, Z. Wu*. A Biodegradable MnSiO3@Fe3O4 nanoplatform for dual-mode MR imaging guided combinatorial cancer therapy. Biomaterials, 2019, 194, 151-160.（IF=15.304）
  45.  X. Sun#, M. Zhang#, R. Du#, X. Zheng, C. Tang, Y. Wu, J. He, W. Huang, Y. Wang, Z. Zhang, X. Han, J. Qian, K. Zhong, X. Tian, L. Wu, G. Zhang, Z. Wu*, D. Zou*. A polyethyleneimine-driven self-assembled nanoplatform for fluorescence and MR dual-mode imaging guided cancer chemotherapy. Chemical Engineering Journal, 2018, 350, 69-78.（IF=16.744）
  46.  X. Sun*, N. Ni, Y. Ma, Y. Wang, D. T. Leong*. Retooling Cancer Nanotherapeutics' Entry into Tumors to Alleviate Tumoral Hypoxia. Small, 2020, 16, 2003000.（IF=15.153）
  47.  Y. Cao, K. Wang, P. Zhu, X. Zou, G. Ma, W. Zhang, D. Wang, J. Wan, Y. Ma, X. Sun*, J. Dong*. A near-infrared triggered upconversion/MoS2 nanoplatform for tumour-targeted chemo-photodynamic combination therapy. Colloids and Surfaces B: Biointerfaces, 2022, 213, 112393.  (IF=5.999）
  48. H. Wang, X. Zhao, H. Zhang, X. Zou, D. Jia, W. Liu, B. Tian, D. Yuan, Y. Li, Y. Zhu, F. Zhang, Y. Dai, Y. Fan, Y. Wei, X. Sun, Q. Fan, J. Dong. EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy. Materials Today Advances, 2023, 18, 100375. (IF=9.918)
  49. T. Tang, Y. Gong*, Y. Gao, X. Pang, S. Liu, Y. Xia, D. Liu, L. Zhu, Q. Fan*, X. Sun*. A pH-Responsive Liposomal Nanoplatform for Co-delivery of a Pt(IV) Prodrug and Cinnamaldehyde for Effective Tumor Therapy. Frontiers in Bioengineering and Biotechnology, 2023, 1191534. (IF=6.064)
  50.  X. Zou, G. Ma, P. Zhu, Y. Cao,  X. Sun*, H. Wang*, J. Dong*. A Polydopamine-Coated Platinum Nanoplatform for Tumor Targeted Photothermal Ablation and Migration Inhibition. Frontiers in Oncology. 2022, 12, 860718.  (IF=5.738）
  51.  X. Zhang, Y. Ma, J. Wan, J. Yuan, D. Wang, W. Wang, X. Sun*, Q. Meng*. Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics. Frontiers in Chemistry, 2021, 9, 768248. (IF=5.545）
  52.  N. Ni, Y. Su, Y. Wei, Y. Ma, L. Zhao*, X. Sun*. Tuning nanosiliceous framework for enhanced cancer theranostic applications. Advanced Therapeutics, 2021, 16, 2000218. (IF=5.003）
  53.  D. Wang, Y. Wang, Q. Lv, X. Zhang, G. Ma, Y. Gao, C. Wang, S. Liu, C. Li*, X. Sun*, J. Wan*. A polyoxometalate encapsulated metal-organic framework nanoplatform for synergistic photothermal-chemotherapy and anti-inflammatory of ovarian cancer. Molecules, 2022, 27(23), 8350. (IF=4.927）

主持的科研项目

[1]国家自然科学基金面上项目，82372031。

[2]国家外专项目，Y20240164。

[3]国家自然科学基金青年项目，22104073。

[4]山东省优青（海外）项目，2022HWYQ-079。

[5]泰山学者青年专家项目，tsqn202408248。

[6]山东省高校“青创科技计划”项目，团队名称：超高场磁共振分子与纳米探针创新团队，2021KJ100。

[7]山东省自然科学基金青年项目，ZR2021QB119。

[8]齐鲁卫生与健康杰出青年人才培育工程。

[9]山东省海外科技人才项目。

[10]济南市“高端外专集聚工程”。

[11] 山东第一医科大学青峰计划，

[12] 2024年度海外客座教授支持计划

[13] 临床-基础联合创新团队项目（3000万），团队名称：肿瘤放射治疗创新团队，基础PI之一

[14] 2025年度新兴战略领域研究培养计划项目（1000万），基础PI

[15] 优势特色临床-基础多学科交叉专项（200万），基础PI

[16]山东省重点研发计划（国际科技合作）（100万），参与

[17]山东第一医科大学附属肿瘤医院学科集群创新工程（300万），参与



申请专利情况

  1. 孙晓，张鑫宇，许学莉，王辰宇，高媛。一种二维硫化铁纳米片及其制备方法和应用，202310727648.8 已授权
  2. 孙晓，张鑫宇，许学莉，马桂琦。一种硫化锰纳米花一体化诊疗制剂及其制备方法和应用，202310647356.3 已授权
  3. 孙晓，王辰宇，田伟，万吉鹏，许学莉，李长忠。一种多功能铁基光热可控释琼脂糖水凝胶系统，202310727782.8 已授权
  4. 孙晓，王辰宇，许学莉，刘慧，梁宇波，宫玉芳。一步法合成Ag/Ag2S Janus异质结及其应用，202310847882.4 已授权
  5. 孙晓，许学莉，董建，郭凯，田丽雅，王颖祺，董梦真，陈明晶。一种氧化钆/钯纳米团簇及其制备方法，2023115652755
  6. 孙晓，郭凯，许学莉，赵新亚，王锡明，刘怀超，马桂琦，任轲。一种靶向肝纤维化的新型钆钯纳米材料及其制备方法和应用，2023115652717 已授权
  7. 孙晓，穆梦瑶，许学莉，李玉琴，侯玥冰。一种可用于酸中毒监控的肿瘤MRI诊疗一体化纳米探针制备与应用，202311765257.1 已授权
  8. 孙晓，穆梦瑶，田丽雅，刘双庆，许学莉。一种铁蛋白-铂-锰磁共振纳米探针、制备方法及其应用，2023114288051 已授权
  9. 许学莉，孙晓，马桂琦，马鹏举，刘慧，陈钱雨。一种聚多巴胺包覆硫化锰纳米簇制剂的制备方法，2023116702681
  10. 许学莉，孙晓，崔瑾，赵新亚，郭凯，田丽雅。靶向肝星状细胞的铁蛋白基磁共振纳米探针的制备方法，2023116115790
  11. 董建，孙晓，刘慧，高培轩，曹玉涛，刘光耀，孙永宾。石墨相氮化碳量子点-硅酸铜-上转换发光纳米颗粒及其制备方法，2023116137802
  12. 孙晓，刘慧，许学莉，郭凯，张萌萌。一种CRISPR/Cas9基因递送系统的制备方法，202411067260.0 已授权
  13. 葛海燕，穆梦瑶，孙晓，田丽雅，代晓辉，宫玉芳。一种双重调控肿瘤PD-L1表达的诊疗一体化纳米探针及其制备方法与应用，202410278070.7 已授权
  14. 周晶，樊庆，孙晓，宫玉芳，马桂琦。一种钆铂放疗增敏剂的制备方法与应用，202410259975.X 已授权
  15. 许学莉，刘奥，孙晓，周厚妊，宫玉芳，马桂琦。一种可同时触发羟基自由基和烷基自由基产生的纳米平台制备方法与应用，202410320137.9 已授权
  16. 刘洁，孙晓，许胜男，裴金利，王世杰，刘婧如，赵琨龙。一种利用聚乙烯亚胺调控制备不同尺寸锰基核磁纳米探针的方法，202410421357.0 已授权
  17. 王锡明，孙晓，刘怀超，郭凯，许学莉，张萌萌。一种双重诊断子宫内膜异位症的银/硫化银纳米探针的制备方法及其应用，202410640305.2 已授权
  18. 万吉鹏，刘怀超，孙晓，代晓辉，田伟。一种可注射的磁热响应性温敏水凝胶的制备方法及应用，202410616762.8 已授权
  19. 赵新亚，宫玉芳，孙晓，黄敏，崔瑾，王锡明。一种抗肝纤维化纳米药物的制备方法及应用，202411587620.X 已授权
  20.  王锡明,周厚妊,孙晓,许学莉,郭凯,田丽雅,王颖祺。一种超声/磁共振双模纳米探针及其制备方法与应用，202411781833.6 
  21. 张倩，宫玉芳，许学莉，孙晓。一种硫化锰纳米球的尺寸调控方法与应用。公开
  22.  周嵩，孙晓，马桂琦，闫博文。一种靶向肝纤维化的钆铂诊疗一体化纳米探针制备及应用。公开
  23. 刘村，袁一诺，刘欣宇，梁萍，孙晓，许学莉。一种T1-T2双模态磁共振造影剂的制备方法和应用。公开
  24. 朱强，田丽雅，许学莉，孙晓，冯跃民。一种可用于肝脏核磁共振成像的纳米探针制备及应用。公开


获奖

  1. 于金明科技创新奖

  2. 山东省材料科技奖一等奖

  3. 山东第一医科大学“优秀教师”

  4. 山东第一医科大学党支部“双带头人”
  5. 山东省医学科技奖三等奖
  6. 山东第一医科大学科学技术二等奖
  7. 山东省医学会青年科技奖三等奖